insights_auto
Why is EII up 4.26%?
Dive Deeperchevron_right
EII:FRA
Eisai Co Ltd
€29.61
arrow_upward
+4.26%(+1.21) 1D
Nov 13, 10:00:00 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EII...
Open
€28.97
High
€29.61
Low
€28.47
Mkt. cap
9.86B
Avg. vol.
239.00
Volume
1.99K
52-wk high
€31.02
52-wk low
€19.70
No. of employees
11K
Open
€28.97
High
€29.61
Low
€28.47
Mkt. cap
9.86B
Avg. vol.
239.00
Volume
1.99K
52-wk high
€31.02
52-wk low
€19.70
No. of employees
11K
News stories
From web sources and news partners
24/7 Wall St.
·
1 hour ago
Gilead Beat the S&P 500 by More Than 25 Points in the Past Year, but $1,000 From a Decade Ago Is Still Worth Less Than $3,500
BigGo Finance
·
3 hours ago
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
The Motley Fool
·
2 hours ago
Tesla Is Down 13% in 2026 While the S&P 500 Is Up. Here’s the 1 Catalyst Left This Year That Could Flip That.
Traders Union
·
1 hour ago
Chris Ciovacco: Semiconductors SMH and S&P 500 SPY show several possible support areas
Profile
Eisai Co., Ltd. is a Japanese pharmaceutical company headquartered in Tokyo, Japan. It has some 10,000 employees, among them about 1,500 in research. Eisai is listed on the Tokyo Stock Exchange and is a member of the Topix 100 and Nikkei 225 stock indices. Wikipedia
About Eisai Co Ltd
CEOHaruo Naito | Haruo Naito
Employees10.5K
FoundedDec 6, 1941
HeadquartersBunkyo City, Tokyo, Japan
SectorHealth Care
IndustryPharmaceutical industry
Websiteeisai.co.jp